MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $201,000 | -74.7% | 10,545 | -61.4% | 0.04% | -81.5% |
Q4 2018 | $794,000 | -18.7% | 27,297 | +28.6% | 0.19% | -1.6% |
Q3 2018 | $977,000 | +23.2% | 21,230 | 0.0% | 0.19% | +18.5% |
Q2 2018 | $793,000 | +71.6% | 21,230 | +35.8% | 0.16% | +65.3% |
Q1 2018 | $462,000 | -58.6% | 15,630 | -45.5% | 0.10% | -19.7% |
Q2 2014 | $1,117,000 | – | 28,700 | +286900.0% | 0.12% | – |
Q4 2013 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
Q3 2013 | $4,069,000 | -14.4% | 173,173 | -2.1% | 0.52% | -19.9% |
Q2 2013 | $4,754,000 | – | 176,938 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |